If we corroborate the cancer type (Table 3a,b), the post-treatment NSE concentrations were highest in patients with SCLC, followed by NSCLC patients (adenocarcinoma), and the smallest increases were registered in squamous carcinoma cases. This evidence concerns the gene ENO2 and squamous cell carcinoma.